Medical Cannabis News

Synonyms: 
mmj
Tue
18
Dec

How to use THC and CBD effectively

Interest in the medical and recreational use of marijuana has led to increased interest in how to best administer the two most abundant cannabinoids in the plant: THC and CBD.  These two molecules typically represent about 70 percent of all of the known cannabinoids in the unadulterated plant. The manner in which THC and CBD are administered plays a critical role in determining the rate and amount of each molecule that is absorbed by the brain.

Mon
17
Dec

The Green Organic Dutchman launches brand new website focused on medical patients and recreational consumers

The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX: TGOD) (US: TGODF) is pleased to announce the launch of its brand new experiential patient and consumer website focused on delivering the absolute best online experience in the industry.

Fri
14
Dec

N.S. getting less than half the legal cannabis it needs to meet demand

Nova Scotia's finance minister says she will be firing off another letter to Health Canada to register the province's concerns over a growing shortage of cannabis.

Karen Casey says Nova Scotia is getting only 35 to 40 per cent of the cannabis it needs to meet demand at government-run outlets and she wants to make that clear to the federal regulator after two previous letters.

Casey says one producer in Nova Scotia has been approved by Ottawa and two more are ready to go, so she's encouraging Health Canada to give them the approval they need.

She says there has been no need yet to close any of the 12 shops run by the Nova Scotia Liquor Corporation because of product shortages, but the situation is being monitored.

Fri
14
Dec

Health Canada recalls two cannabis strains sold in Sask. pot shops

Health Canada has recalled two cannabis strains which were sold in three stores in Saskatchewan.

The recalls involve the 3.5 grams of Cherry Lime and Warlock Kush cannabis strains produced by Bonify Ltd. which is based out of Manitoba.

According to the alert, 52 units of product were sold at three cannabis retailers: Cannabis Co. in Regina, Spiritleaf in Moose Jaw, and The Pot Shack in Saskatoon. The affected cannabis products were sold between November 20 and November 30.

Although the national public health organization hasn’t received any complaints yet, it said the products do not meet some of the microbial and chemical contaminant limits set by federal cannabis regulations.

Thu
13
Dec

What you need to know about giving pot to your sick pooch

More research is needed to determine whether giving sick pets pot helps or hurts them, according to a Nova Scotia veterinarian who has seen an increase in the number of animals brought to his practice after consuming the drug.

Right now, it's illegal for a vet to prescribe cannabis products, although there's research underway that could change that. Canopy Growth Corp. has been given the green light by Health Canada to research the affect a compound in cannabis called CBD has on treating anxious animals.

While the THC in marijuana can get people high, CBD doesn't have the same psychoactive properties and is often consumed in oil form.

Thu
13
Dec

Canada’s military veterans are finding a home in corporate cannabis

One of the many wounds veterans can carry home with them from conflict is the toll stress and trauma takes on the human mind. While there are many medical uses for cannabis, one area in which it has been finding significant success is the treatment of post-traumatic stress disorder (PTSD).

“I was using [cannabis] for night terrors and night sweats,” Kevin Dunne, a non-commissioned officer in the Canadian Army. “I was dealing with for the last six years after coming back from Afghanistan, and then in six months I found that my dreams are different, my night sweats had stopped.

Dunne retired from the Canadian Forces in 2012 after 22 years in the service. He was taking nine different medications a day to treat his PTSD. When he slept, he was plagued with night terrors.

Thu
13
Dec

Aphria signs medical marijuana supply deal with Paraguay firm

Marijuana producer Aphria Inc. (APHA.TO 5.12%) has signed a letter of intent to supply a company in Paraguay with medical cannabis.

Under the agreement, Aphria will supply Insumos Medicos S.A., a pharmaceutical manufacturing, import and distribution company.

Aphria says Insumos will undertake the registration of the Canadian company's products in Paraguay and the appropriate licensing for the import of medical cannabis.

Paraguay will become the Ontario company's third market in Latin America, following Argentina and Colombia.

Aphria has been under pressure in recent days after short-sellers alleged the company bought assets in Colombia, Argentina and Jamaica at "vastly inflated prices."

Thu
13
Dec

Hemp-based CBD products poised to explode waiting on impending hemp farm bill

Even though this year's farm bill has been delayed, everyone is closely monitoring events lately as hemp and hemp-derived CBD is likely to become federally legal in the U.S. as early as next week. The CBD market, already generating annual revenues in the millions, is poised for another massive boost with the impending passing of the 2018 Farm Bill as investors expressed optimism. Effectively legalizing CBD, the market is projected to explode as obstacles are lessened or completely nixed, allowing companies to maximize their earnings potential with respect to CBD-based products. The Brightfield Group estimates the CBD market will be 40 times its current size in just four years.

Wed
12
Dec

Cannaquestions: Using cannabis to address multiple sclerosis, pain and nausea

Q1: I’ve got MS. What’s cannabis for?

Lawrence is certainly not alone. An estimated one in every 385 Canadians are living with multiple sclerosis (MS), which both Statistics Canada and the MS Society of Canada report is one of the highest incidence in the world. An autoimmune disease of the central nervous system, MS inflames and damages the myelin sheath that protects the nerves, disrupting the signals transmitted along them.

Wed
12
Dec

Small cannabis growers find roadblocks on path to microcultivation licences

Without warning, his baby had stopped breathing, and he frantically performed CPR while his friend James Gallagher called 911.

Years later, the men still become emotional remembering that day. Boissonneault learned that his daughter had a rare disorder that caused epilepsy, and when pharmaceutical medications failed to cure her seizures, he turned to CBD oil, a non-psychoactive substance in marijuana.

Pages

Subscribe to RSS - Medical Cannabis News